RT @drpablocorral
CRISPR and cardiovascular diseases
“CRISPR editing unequivocally has transformed biomedical research and promises to do the same for cardiovascular medicine, ushering in a new paradigm of ‘one-and-done’ therapies”
RT @cardiomet_CE
1) Welcome to an #accredited #tweetorial on the mechanisms of action of lipid lowering drugs. My focus is #statins, #PCSK9 agents, & #inclisiran. Accredited for 0.50h CE/#CME. I am Pam Taub MD @PamTaubMD, Professor of Medicine at @UCSDHealth.
#FOAMed @MedTweetorials
#accredited #tweetorial #statins #pcsk9 #inclisiran #FOAMed
A nice overview on #PCSK9 #inhibitors and related #medchem opportunities.
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.2c01290
A nice overview on #pcsk9 #inhibitors and releted #medchem opportunities
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.2c01290